Tag: bd
ESKD Summit 2023: What matters to patients gains momentum with input...
This advertorial is sponsored by BD.
Focusing on the disease through the patient’s lens, establishing well-functioning multidisciplinary teams, to potentially enhance both the patient’s journey...
Multidisciplinary community unites at inaugural patient-focused ESKD Summit
This advertorial, sponsored by BD, is only available in selected countries and geographies.
“The Changing Face of a Dialysis Patient” was the central theme...
History warns us against “optimistic exuberance” in drug-coated balloon trials
The importance of assessing clinical trial data in an objective, balanced way has been borne out by recent history in the vascular surgery space,...
AVeVA study confirms benefit of covered stent placement in graft-vein anastomotic...
A prospective, multicentre study involving the Covera vascular covered stent (BD) has confirmed the benefits of immediate, post-percutaneous transluminal angioplasty (PTA) placement of the...
Vascular access creation: EndoAVF keeps future options open, but is not...
Based on over four years of experience in a single centre, Robert Shahverdyan (Asklepios Klinik Barmbek, Hamburg, Germany) claims that endovascular arteriovenous fistula (endoAVF)...
Largest patient series to date reinforces 4Fr WavelinQ system’s potential in...
A multicentre experience with the 4 French (4Fr) WavelinQ endoAVF system (BD) has found that the device is safe and effective, bolstering existing evidence...
Study indicates lower wound infection and surgical reintervention rates in pAVF...
A single-centre, retrospective, comparative study, which was presented at the July 2021 Journal of Vascular Surgery (JVS) Journal Club (14 July, online), has found...
The WavelinQ™ EndoAVF System takes an innovative approach in creating endovascular...
NOTE: This advertorial is ONLY available to watch in selected countries and geographies
This advertorial, sponsored by BD, is intended for readers in the...
BD announces enrolment in postmarket studies of the WavelinQ endoAVF system
BD announced today that enrolment has begun and the first patients have been treated in the postmarket surveillance study, CONNECT-AV.
CONNECT-AV is a prospective, single-arm,...
BD gains FDA 510(k) clearance for Pristine long-term haemodialysis catheter
American medical technology company BD (Becton, Dickinson and Company) has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Pristine...